Boston Scientific Corporation develops medical solutions for non-surgical, endoscopic weight loss through its Endura Weight Loss Solutions platform. Launched after Boston Scientific acquired Apollo Endosurgery in 2024, Endura brings procedures such as ESG and TORe to patients seeking alternatives to surgery, with internal suturing and other approaches performed through the mouth rather than through incisions.